PMCB Historical PE Ratio image   This PMCB PE ratio history page last updated 9/19/2022
PMCB PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
9/14/2022
2.59-0.07-0.17NA
Q4 2022
7/28/2022
2.39-0.06-0.80NA
Q3 2022
3/15/2022
2.08-0.04NANA
Q2 2022
12/14/2021
2.40-0.06NANA
Q1 2022
9/14/2021
3.27-0.64NANA
PMCB Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
9/14/2022
2.59-0.07-0.28NA
Q4 2022
7/28/2022
2.39-0.06-0.24NA
Q3 2022
3/15/2022
2.08-0.04-0.16NA
Q2 2022
12/14/2021
2.40-0.06-0.24NA
Q1 2022
9/14/2021
3.27-0.64-2.56NA
Quotes delayed 20 minutes

Email EnvelopeFree PMCB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
PharmaCyte Biotech (PMCB) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PMD PE Ratio History
PMVP PE Ratio History
POAI PE Ratio History
PODD PE Ratio History
PRAH PE Ratio History
PRAX PE Ratio History
PRCT PE Ratio History
PRGO PE Ratio History
PRLD PE Ratio History
PROG PE Ratio History
On this page we presented the PMCB PE Ratio History information for PharmaCyte Biotech' stock. The average PMCB PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PMCB PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PMCB PE ratio history result, against the recent PE: when this page was posted on 9/16/2022, the most recent closing price for PMCB had been 2.72, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on PMCB or any other given stock, valuation analysis for PMCB can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate PharmaCyte Biotech PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for PMCB. Thanks for visiting, and the next time you need to research PMCB PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: TLN Historical Stock Prices, Top Ten Hedge Funds Holding YMAR, OLEM shares outstanding history.

 

PMCB PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.